Tag: Drug Marking

Russian CDAT and Siemens Signed Agreement on Strategic Partnership

marking
The Center for the Development of Advanced Technologies (CDAT), the operator of the Russian information system for digital labeling and tracking of goods, and Siemens signed an agreement on strategic ...

Speeding Up Implementation of Drug Marking in Russia

Simplification of the printing technology of the drug labeling code, including its length shortening may speed up implementation of the drug labeling in Russia, reports the press service of the Center...

French pharma company Cristers to use Adents serialisation solution

marking
Adents had its Adents Prodigi cloud serialisation solution chosen by French pharmaceutical company Cristers to ensure compliance with the EU Falsified Medicines Directive (FMD).

13,000 drugs have already passed through the tracking system in Russia

marking
The functions of the operator of the information system for monitoring the movement of drugs were transferred to the Center for the Development of Advanced Technologies.

Over 10,000 Russian pharma market participants joined the labeling system

marking
According to the head of Roszdravnadzor, about 10,000 of pharma market participants across the country have joined the program for monitoring of preparedness for the project on the labeling of drugs.

Recipharm released the first EU FMD compliant products to Europe

drug-serialization
Recipharm, a leading contract development and manufacturing organisation (CDMO), has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.

Recipharm receives EMVO approval

recipharm
Recipharm, a leading contract development and manufacturing organisation has received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub.

SID&GP presented results of manufacturers survey

marking
Vladislav Shestakov took part in the meeting dedicated to labeling of pharmaceutical products where he discussed prospects of pharmaceutical labeling.

Russian government extended drug labeling pilot project until the end of 2019

drug-marking
Russian Prime Minister, Dmitry Medvedev, signed resolution, according to which in order to provide information and technical support to the priority drug labeling project .

Schreiner MediPharm created Covert-Hologram Seal for tamper protection

drug-marking
Schreiner MediPharm has developed a multifunctional Covert-Hologram Seal that offers reliable first-opening indication and tamper evidence, plus counterfeiting protection.

TraceLink rolls out its Russian serialization solution

trackandtrace
TraceLink announced its Russian compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting for all pharmaceutical manufacturers.

Wasdell Group started serialization service

marking
The Wasdell Group, a leading partner to companies within the pharmaceutical, medical device and clinical trials industries, has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlines.

Four more pharma manufacturers will receive loans to buy labeling equipment

ozon-pharm
IDF programs allow Russian companies to access preferential loan financing required for launching the manufacturing of unique local products, as well as the analogs of advanced international products.

Recipharm starts its standalone serialisation service

recipharm
Recipharm, a leading contract development and manufacturing organisation (CDMO) has announced the launch of its standalone serialisation service ahead of the introduction of the EU Falsified Medicines Directive (FMD).

IBI Lorenzini will use TraceLink’s serialization solutions

marking
TraceLink, the world’s largest track and trace network, announced that IBI Lorenzini has selected TraceLink’s solutions to ensure compliance with global serialization regulations.

The cost of drug labeling implementation is considered as reasonable

drug-marking
According to market participants, the costs of drug manufacturers on mandatory implementation of labeling by 2020 will not increase the cost of drugs.